<?xml version="1.0" encoding="UTF-8"?>
<ref id="B1">
 <label>1.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Verweij</surname>
    <given-names>PE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chowdhary</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Melchers</surname>
    <given-names>WJG</given-names>
   </name>, 
   <name name-style="western">
    <surname>Meis</surname>
    <given-names>JF</given-names>
   </name>
  </person-group>
  <year>2016</year>
  <article-title>Azole resistance in 
   <italic>Aspergillus fumigatus</italic>: can we retain the clinical use of mold-active antifungal azoles?
  </article-title>
  <source>Clin Infect Dis</source>
  <volume>62</volume>:
  <fpage>362</fpage>â€“
  <lpage>368</lpage>. doi:
  <pub-id pub-id-type="doi">10.1093/cid/civ885</pub-id>.
  <pub-id pub-id-type="pmid">26486705</pub-id>
 </mixed-citation>
</ref>
